PC
Prostate cancer
From low-risk disease appropriate for active surveillance to locally advanced and high-risk cases requiring robotic prostatectomy or multi-modality therapy. Genomic-informed decision making at every stage.
Learn more ›
BC
Bladder cancer
Non-muscle and muscle-invasive bladder cancer, including bladder-sparing approaches, robotic cystectomy with nerve-sparing, and TURBT.
KC
Kidney cancer
Robotic and open partial nephrectomy, complex renal mass surgery, nephroureterectomy, and management of advanced kidney cancer with medical oncology.
TC
Testicular cancer
Surgical management of early and advanced testicular cancer, including post-chemotherapy retroperitoneal lymph node dissection (RPLND) and orchiectomy.
PE
Penile cancer
Diagnosis and surgical management of penile cancer, with attention to oncologic control and quality-of-life outcomes.
AD
Adrenal cancer & nodules
Evaluation and surgical management of adrenal masses and cancers, including partial and total adrenalectomy.
FT
HIFU focal therapy
For carefully selected men with localized prostate cancer, high-intensity focused ultrasound treats only the cancer and spares the rest of the prostate, preserving urinary and sexual function.
AS
Active surveillance
Structured monitoring for low-risk prostate cancer, with MRI, PSA kinetics, and biomarker-guided protocols to safely defer or avoid treatment.
DX
Advanced diagnostics
Transperineal and MRI-guided prostate biopsy, PSMA PET coordination, genomic risk testing, and evaluation of hematuria, elevated PSA, and incidental kidney or adrenal findings.
